Aging Features of Hair and Scalp
Conditions
Interventions
G1: Aged 18-24 (<25):No Intervention
G2: Aged 25-29:No Intervention
G3: Aged 30-34:No Intervention
G4: Aged 35-39:No Intervention
G5: Aged 40-44:No Intervention
G6: Aged 45-49:No Intervention
G7: Aged 50-54:No Intervention
G8: Aged 55-59:No Intervention
G9: Aged 60-69:No Intervention
Sponsors
Disease Hospital, Skin Disease Hospital of Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: Subjects must meet all of the following criterias: 1. Good awareness of the content, and the subject understands and signs the Informed Consent Form; 2. The subject indicates willingness to complete all steps in the reasearch; 3. Male and female, aged 18-69 years; 4. Good physical health with healthy scalp and hair, no skin damage; 5. Hair length longer than 5 cm; 6. Those who have not had hair dyeing, permming, styling and other special hair treatment in the past 1 month; 7. Persons who adhere to the provisions of lifestyle precautions throughout the reasearch period.
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criterias should be excluded: 1. Pregnant or lactating women; 2. Patients with moderate or severe androgenic alopecia, alopecia areata, inflammatory cicatricial alopecia or other hair diseases; 3. Patients with clinically uncured inflammatory skin diseases; 4. Suffering from systemic diseases such as cardiovascular, endocrine or metabolic diseases; 5. Patients with asthma or other chronic respiratory diseases who are being treated; 6. Those who have received anti-cancer chemotherapy within the last 6 months; 7. Patients with immune deficiency or autoimmune diseases, or with infectious diseases; 8. Suffering from mental or mental illness; Or have sleep, emotional controlling disorders or irregular life; 9. Have used cosmetics, health care products or other products with anti-hair loss or hair growth efficacy in the past 3 months; 10. Anyone who has used any medicine that affects hair growth in the last 6 months, including oral finasteride tablets (Propecia, Prolicide, etc.), or topically use of any preparation containing minoxidil (e.g., Mandi); 11. People who have had hair transplants; 12. People with very curling hair; 13. People with high physical sensitivity; 14. Have participated in other clinical trials within the last 3 months; 15. Participants were deemed unsuitable for the trial by clinical evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 60 Times Combing Method (Hair Loss Counts);60 Times Combing Method (Hair Breakage Counts);Clinical Grading 1 (Graying Hair Ratio);Clinical Grading 2 (Hair Glossiness);Clinical Grading 3 (Hair Splitting);Clinical Grading 4 (Hair Elasticity);Clinical Grading 5 (Hair Smoothness);Clinical Grading 6 (Hair Strengthness);Clinical Grading 7 (Dandruff Grade);Instrumental Testing 1 (Scalp Sebum Content);Instrumental Testing 2 (Scalp Water Content);Instrumental Testing 3 (Scalp Glossiness);Instrumental Testing 4 (Scalp Transepidermal Water Loss);Instrumental Testing 5 (Scalp Density);Instrumental Testing 6 (Scalp Erythema);Instrumental Testing 7 (Scalp pH);Instrumental Testing 8 (Scalp Thickness);Trichoscopy Dermoscopy 1: Dandruff Photograph;Trichoscopy Dermoscopy 2: Hair Density;Trichoscopy Dermoscopy 3: Follicle Counts with Single/Multiple Hair Fibers;Trichoscopy Dermoscopy 4: Hair Ratio at Anagen/Telogen Stage;Trichoscopy Dermoscopy 5: Hair Growth Rate; | — |
Countries
China
Contacts
Public ContactWencai Jiang
Shanghai Skin Disease Hospital, Skin Disease Hospital of Tongji University
Outcome results
None listed